A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...